272 related articles for article (PubMed ID: 34511369)
1. Extracorporeal Shockwave Therapy in Peyronie's Disease: Systematic Review and Meta-Analysis.
Bakr AM; El-Sakka AI
J Sex Med; 2021 Oct; 18(10):1705-1714. PubMed ID: 34511369
[TBL] [Abstract][Full Text] [Related]
2. Shockwave Therapy in the Treatment of Peyronie's Disease.
Krieger JR; Rizk PJ; Kohn TP; Pastuszak A
Sex Med Rev; 2019 Jul; 7(3):499-507. PubMed ID: 30926460
[TBL] [Abstract][Full Text] [Related]
3. Updated recommendations on the therapeutic role of extracorporeal shock wave therapy for peyronie's disease: systematic review and meta-analysis.
Wang X; Liu H; Tang G; Wu G; Chu Y; Wu J; Cui Y
BMC Urol; 2023 Sep; 23(1):145. PubMed ID: 37700253
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain.
Fojecki GL; Tiessen S; Osther PJ
World J Urol; 2017 Jan; 35(1):1-9. PubMed ID: 27108421
[TBL] [Abstract][Full Text] [Related]
5. Review of the Current Status of Low Intensity Extracorporeal Shockwave Therapy (Li-ESWT) in Erectile Dysfunction (ED), Peyronie's Disease (PD), and Sexual Rehabilitation After Radical Prostatectomy With Special Focus on Technical Aspects of the Different Marketed ESWT Devices Including Personal Experiences in 350 Patients.
Porst H
Sex Med Rev; 2021 Jan; 9(1):93-122. PubMed ID: 32499189
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment?
Poulakis V; Skriapas K; de Vries R; Dillenburg W; Ferakis N; Witzsch U; Melekos M; Becht E
Asian J Androl; 2006 May; 8(3):361-6. PubMed ID: 16625288
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal shock wave therapy in Peyronie's disease: results of a placebo-controlled, prospective, randomized, single-blind study.
Hatzichristodoulou G; Meisner C; Gschwend JE; Stenzl A; Lahme S
J Sex Med; 2013 Nov; 10(11):2815-21. PubMed ID: 23898925
[TBL] [Abstract][Full Text] [Related]
8. [Low-intensity extracorporeal shockwave therapy for Peyronie's disease: A preliminary study of 32 cases].
Li PC; Chen X; Zhu XB; Shi T; Song F; Huang HW; Zhang XS
Zhonghua Nan Ke Xue; 2018 Apr; 24(4):340-344. PubMed ID: 30168955
[TBL] [Abstract][Full Text] [Related]
9. Low-intensity laser diode plus extracorporeal shock wave therapy: a new treatment strategy in the management of Peyronie's disease.
Dell'Atti L; Ronchi P
World J Urol; 2023 Sep; 41(9):2563-2568. PubMed ID: 37490060
[TBL] [Abstract][Full Text] [Related]
10. Non-surgical therapies for Peyronie's disease.
Rosenberg JE; Ergun O; Hwang EC; Risk MC; Jung JH; Edwards ME; Blair Y; Dahm P
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD012206. PubMed ID: 37490423
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal shockwave therapy for Peyronie's disease does not correct penile deformity.
Strebel RT; Suter S; Sautter T; Hauri D
Int J Impot Res; 2004 Oct; 16(5):448-51. PubMed ID: 14973523
[TBL] [Abstract][Full Text] [Related]
12. Low-Intensity Shock Wave Therapy in Sexual Medicine-Clinical Recommendations from the European Society of Sexual Medicine (ESSM).
Capogrosso P; Frey A; Jensen CFS; Rastrelli G; Russo GI; Torremade J; Albersen M; Gruenwald I; Reisman Y; Corona G
J Sex Med; 2019 Oct; 16(10):1490-1505. PubMed ID: 31447380
[TBL] [Abstract][Full Text] [Related]
13. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease.
Palmieri A; Imbimbo C; Longo N; Fusco F; Verze P; Mangiapia F; Creta M; Mirone V
Eur Urol; 2009 Aug; 56(2):363-9. PubMed ID: 19473751
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials.
Hauck EW; Mueller UO; Bschleipfer T; Schmelz HU; Diemer T; Weidner W
J Urol; 2004 Feb; 171(2 Pt 1):740-5. PubMed ID: 14713800
[TBL] [Abstract][Full Text] [Related]
15. Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach.
Hauck EW; Hauptmann A; Bschleipfer T; Schmelz HU; Altinkilic BM; Weidner W
J Urol; 2004 Jan; 171(1):296-9. PubMed ID: 14665898
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease.
Gao L; Qian S; Tang Z; Li J; Yuan J
Int J Impot Res; 2016 Sep; 28(5):161-6. PubMed ID: 27250868
[TBL] [Abstract][Full Text] [Related]
17. [Extracorporeal shock wave therapy for Peyronie's disease].
Ochoa A; Guillot-Tantay C; Faix A; Misrai V; Rouprêt M
Prog Urol; 2020 Sep; 30(10):488-499. PubMed ID: 32370921
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of extracorporeal shockwave therapy for Peyronie's disease.
Srirangam SJ; Manikandan R; Hussain J; Collins GN; O'Reilly PH
J Endourol; 2006 Nov; 20(11):880-4. PubMed ID: 17144855
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of extracorporeal shock wave therapy for acute Peyronie's disease: a 10-year retrospective analysis.
Spirito L; Manfredi C; La Rocca R; Napolitano L; Preto M; Di Girolamo A; Arcaniolo D; De Sio M; Creta M; Longo N
Int J Impot Res; 2024 Apr; 36(2):135-139. PubMed ID: 36788352
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Peyronie's disease by extracorporeal shockwave therapy: evaluation of our preliminary results.
Abdel-Salam Y; Budair Z; Renner C; Frede T; Rassweiler J; El-Annany F; El-Magraby H; El-Akkad M
J Endourol; 1999 Oct; 13(8):549-52. PubMed ID: 10597123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
